Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05837923 · ClinicalTrials.gov registry record · NA
Radicle Relief 2: A Study of Health and Wellness Products on Pain and Health Outcomes
A NA study, sponsored by Radicle Science.
- Completed
- Registry status
- NA
- Development phase
- 2,016
- Enrollment target
NCT05837923: Completed NA study, sponsored by Radicle Science.
NCT05837923 is a NA study that has completed, run by Radicle Science. The registered enrollment target is 2,016 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05837923, a NA study, has completed, sponsored by Radicle Science.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,016 participants
- Enrollment target
Study Summary
A randomized, blinded, placebo-controlled study assessing the impact of health and wellness products on pain and other health outcomes
Primary Outcome
Mean difference in pain interference score as assessed by Patient Reported Outcome Measurement System (PROMIS) Pain Interference 6A (scale 6-30; with higher scores corresponding to greater pain interference)
Interventions
- DIETARY_SUPPLEMENT Placebo Control Form 1
- DIETARY_SUPPLEMENT Placebo Control Form 2
- DIETARY_SUPPLEMENT Relief Active Study Product 1.1 Usage
- DIETARY_SUPPLEMENT Relief Active Study Product 1.2 Usage
- DIETARY_SUPPLEMENT Relief Active Study Product 2.1 Usage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,016 participants |
| Start Date | 2024-05-28 |
| Est. Completion | 2024-07-17 |
| Phase | NA |
What the finished NCT05837923 record still lists
NCT05837923 is an interventional study that assigns participants to a tested intervention. Its 2,016 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% higher).
The record links to 0 conditions, and to 5 interventions - of which Placebo Control Form 1 is the first listed.
NCT05837923 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05837923 about?
NCT05837923 is a clinical study titled "Radicle Relief 2: A Study of Health and Wellness Products on Pain and Health Outcomes". A randomized, blinded, placebo-controlled study assessing the impact of health and wellness products on pain and other health outcomes
What is the current status of trial NCT05837923?
This trial is currently completed. It is a NA study. The enrollment target is 2,016 participants. The study started on 2024-05-28. Estimated completion is 2024-07-17.
What interventions are being tested in trial NCT05837923?
The interventions under investigation include: Placebo Control Form 1 (DIETARY_SUPPLEMENT), Placebo Control Form 2 (DIETARY_SUPPLEMENT), Relief Active Study Product 1.1 Usage (DIETARY_SUPPLEMENT), Relief Active Study Product 1.2 Usage (DIETARY_SUPPLEMENT), Relief Active Study Product 2.1 Usage (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05837923?
This trial is sponsored by Radicle Science, which has 55 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05837923's enrollment target sits among peer trials
2,016 52nd of 2000 higher than 1,949 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05059444 · 2,020 participants
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- NCT04604509 · 2,010 participants · Phase 4
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
- NCT04100564 · 2,009 participants · NA
LITES Task Order 0005 Prehospital Airway Control Trial (PACT)
- NCT04216732 · 2,030 participants
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI